Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-12

Clinical Trial Update: Dextromethorphan Added on for Children With Chronic Irritability [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update indicates dextromethorphan is being added for children with chronic irritability, under an irritable mood condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)

Snippet

Sponsor: Tri-Service General Hospital | Conditions: Irritable Mood | Phase 4 | Status: UNKNOWN